4//SEC Filing
Nabriva Therapeutics Plc 4
Accession 0001179110-17-010365
CIK 0001703287other
Filed
Jul 12, 8:00 PM ET
Accepted
Jul 13, 9:22 PM ET
Size
8.9 KB
Accession
0001179110-17-010365
Insider Transaction Report
Form 4
HBM BIOVENTURES CAYMAN LTD
10% Owner
Transactions
- Sale
Ordinary Shares
2017-07-13$10.54/sh−39,914$420,757→ 2,512,007 total - Sale
Ordinary Shares
2017-07-11$10.52/sh−3,521$37,027→ 2,565,661 total - Sale
Ordinary Shares
2017-07-12$10.50/sh−13,740$144,271→ 2,551,921 total
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These ordinary shares were sold in multiple transactions ranging from $10.50 to $10.59 Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each separate price.
- [F2]The price reported in Column 4 is a weighted average price. These ordinary shares were sold in multiple transactions ranging from $10.50 to $10.52 Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each separate price.
- [F3]The price reported in Column 4 is a weighted average price. These ordinary shares were sold in multiple transactions. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each separate price.
Documents
Issuer
Nabriva Therapeutics Plc
CIK 0001703287
Entity typeother
IncorporatedIreland
Related Parties
1- filerCIK 0001703287
Filing Metadata
- Form type
- 4
- Filed
- Jul 12, 8:00 PM ET
- Accepted
- Jul 13, 9:22 PM ET
- Size
- 8.9 KB